Shanghai OPM Biosciences' shareholder Shanghai Panxin has cumulatively reduced its stake in the company by 2.63%.

Shanghai OPM Biosciences (688293.SH) announced that on February 22, 2025, the company received a "Notice of Share Reduction Results" from Shanghai Pan Xin, a shareholder holding more than 5% of the shares. During this share reduction plan, Shanghai Pan Xin reduced the company's shares by 1.1353 million shares through centralized auction trading and reduced the company's shares by 1.8545 million shares through block trading, totaling 2.9898 million shares. The total reduction ratio is 2.63% of the company's current total share capital. As of the disclosure date of the announcement, the time for this share reduction plan has expired.